A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- Healx Limited
- Study ID
- NCT06541847
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Neurofibromatosis Type 1
Eligibility Criteria
- Sex
- ALL
- Age
- 12 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- HLX-1502 — DRUGParticipants will take an oral dose three times a day (with or without food) for up to 24 cycles (a cycle is defined as 28 days).
Study Details
The trial will be an open label, single arm, phase 2 study to assess the tolerability and efficacy of HLX-1502 in participants with NF1 that are 16 years or older in age with progressive and/or symptomatic PN. This study will also investigate the safety and efficacy of HLX-1502 in a small cohort of 12 to 15 year olds.
Key Dates
- Start date
- Feb 10, 2025
- Status verified
- May 2026
- Primary completion
- Jun 30, 2027
- Completion
- Jan 31, 2028
Study Design
- Enrollment
- 25 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: HLX-1502Participants will take an oral dose three times a day (with or without food) for 12 cycles. A cycle is defined as 28 days. Participants with a partial response or stable disease with a previously progressive tumor and/or clinical improvement can continue therapy for an additional 12 cycles for a total of 24 cycles.
Primary Outcome Measure
PN response rate [ Time Frame: 12 months ]
Central Contacts
- Karen Cole-Plourde(205) 934-5140
- Lauren Baldwin
Locations (14)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35294 | Brian Roberts Girish Dhall (PRINCIPAL_INVESTIGATOR) Laura Katherine Metrock (SUB_INVESTIGATOR) |
| Children's Hospital Los Angeles | Los Angeles | California | 90027 | Sandy Gutierrez Tena Rosser (PRINCIPAL_INVESTIGATOR) Nathan Robison (SUB_INVESTIGATOR) Ashley Margol (SUB_INVESTIGATOR) Tom Davidson (SUB_INVESTIGATOR) Katrina O'Halloran (SUB_INVESTIGATOR) Sara-Jane Oneyeama (SUB_INVESTIGATOR) Anat Erdreich-Epstein (SUB_INVESTIGATOR) Kaaren Waters (SUB_INVESTIGATOR) Vless Trinidad (SUB_INVESTIGATOR) Kasey Rangan (SUB_INVESTIGATOR) |
| Stanford University | Palo Alto | California | 94304 | Jenika Maala Cynthia Campen (PRINCIPAL_INVESTIGATOR) Sonia Partap (SUB_INVESTIGATOR) Paul Fisher (SUB_INVESTIGATOR) Katherine Ryan (SUB_INVESTIGATOR) |
| Children's Hospital Colorado | Aurora | Colorado | 80045 | Sarah Dickens Nicholas Foreman (PRINCIPAL_INVESTIGATOR) Holly Lindsay (SUB_INVESTIGATOR) Shelby Winzent-Oonk (SUB_INVESTIGATOR) Molly Hemenway (SUB_INVESTIGATOR) |
| Children's National Hospital | Washington D.C. | District of Columbia | 20010 | Grace Birmingham Benjamin Siegel (PRINCIPAL_INVESTIGATOR) Roger Packer (SUB_INVESTIGATOR) Lindsay Kilburn (SUB_INVESTIGATOR) AeRang Kim (SUB_INVESTIGATOR) Amy Hont (SUB_INVESTIGATOR) Liny John (SUB_INVESTIGATOR) Brian Rood (SUB_INVESTIGATOR) Eugene Hwang (SUB_INVESTIGATOR) Holly Meany (SUB_INVESTIGATOR) |
| Ann & Robert H. Lurie Children's Hospital of Chicago | Chicago | Illinois | 60611 | Kelly Bruno Miriam Bornhorst (PRINCIPAL_INVESTIGATOR) Angela Waanders (SUB_INVESTIGATOR) Ashley Plant (SUB_INVESTIGATOR) Alicia Lenzen (SUB_INVESTIGATOR) Maggie Seblani (SUB_INVESTIGATOR) |
| University of Chicago | Chicago | Illinois | 60637 | Cynthia MacKenzie James Tonsgard (PRINCIPAL_INVESTIGATOR) Shawn Damodharan (SUB_INVESTIGATOR) |
| Indiana University | Indianapolis | Indiana | 46202 | Sara Quetant Steven Rhodes (PRINCIPAL_INVESTIGATOR) Scott Coven (SUB_INVESTIGATOR) Jayne Vonbergen (SUB_INVESTIGATOR) Brian Weiss (SUB_INVESTIGATOR) Kathryn Nevel (SUB_INVESTIGATOR) |
| Johns Hopkins Hospital | Baltimore | Maryland | 21287 | Joshua Roberts Jaishri Blakeley (PRINCIPAL_INVESTIGATOR) Shannon Langmead (SUB_INVESTIGATOR) Carlos Romo (SUB_INVESTIGATOR) Kelly Wypych (SUB_INVESTIGATOR) |
| Washington University School of Medicine | St Louis | Missouri | 63110 | Audrey Merz Amy Armstrong (PRINCIPAL_INVESTIGATOR) Angela Hirbe (SUB_INVESTIGATOR) Brian Van Tine (SUB_INVESTIGATOR) Mia Weiss (SUB_INVESTIGATOR) Mohamed Abdelbaki (SUB_INVESTIGATOR) Nicole Brossier (SUB_INVESTIGATOR) Andrew Cluster (SUB_INVESTIGATOR) Frederick Huang (SUB_INVESTIGATOR) Allison King (SUB_INVESTIGATOR) Bryan Sisk (SUB_INVESTIGATOR) Daniel Willis (SUB_INVESTIGATOR) David Wilson (SUB_INVESTIGATOR) Sanita Burgic (SUB_INVESTIGATOR) Linda Goldenberg (SUB_INVESTIGATOR) Loren Abernathy (SUB_INVESTIGATOR) Christina Carey (SUB_INVESTIGATOR) Leslie Glover (SUB_INVESTIGATOR) Ashley Meyer (SUB_INVESTIGATOR) Andrea Ogle (SUB_INVESTIGATOR) Camille Skaer (SUB_INVESTIGATOR) Molly Warner (SUB_INVESTIGATOR) |
| New York University Langone Health | New York | New York | 10016 | Anna Yaffe Kaleb Yohay (PRINCIPAL_INVESTIGATOR) Jessica Clymer (SUB_INVESTIGATOR) Devorah Segal (SUB_INVESTIGATOR) Jordie Blum (SUB_INVESTIGATOR) |
| Cincinnati Children's Hospital Medical Center | Cincinnati | Ohio | 45229 | Lori Backus Peter De Blank (PRINCIPAL_INVESTIGATOR) Erin Breese (SUB_INVESTIGATOR) Karen Burns (SUB_INVESTIGATOR) Ellen Chang (SUB_INVESTIGATOR) Richard Graham (SUB_INVESTIGATOR) Trent Hummel (SUB_INVESTIGATOR) LaQuita Jones (SUB_INVESTIGATOR) Lynn Lee (SUB_INVESTIGATOR) Benjamin Mizukawa (SUB_INVESTIGATOR) Aaron Mochizuki (SUB_INVESTIGATOR) Robin Norris (SUB_INVESTIGATOR) John Perentesis (SUB_INVESTIGATOR) Christine Phillips (SUB_INVESTIGATOR) Natasha Pillay-Smiley (SUB_INVESTIGATOR) Jonathan Bender (SUB_INVESTIGATOR) Thomas Galletta (SUB_INVESTIGATOR) Joseph Pressey (SUB_INVESTIGATOR) Lauren Pommert (SUB_INVESTIGATOR) |
| Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | Ratnakar Patti Michael Fisher (PRINCIPAL_INVESTIGATOR) Jean Belasco (SUB_INVESTIGATOR) Stephanie Brosius (SUB_INVESTIGATOR) Kristina Cole (SUB_INVESTIGATOR) Jessica Foster (SUB_INVESTIGATOR) Cassie Kline (SUB_INVESTIGATOR) Chelsea Kotch (SUB_INVESTIGATOR) Jane Minturn (SUB_INVESTIGATOR) Amish Shah (SUB_INVESTIGATOR) |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390 | Omar Raslan Laura Klesse (PRINCIPAL_INVESTIGATOR) Justin Jordan (SUB_INVESTIGATOR) Michael Youssef (SUB_INVESTIGATOR) Evan Noch (SUB_INVESTIGATOR) Elizabeth Maher (SUB_INVESTIGATOR) Daniel Bowers (SUB_INVESTIGATOR) Jonathan Wickiser (SUB_INVESTIGATOR) Alexis Kennedy (SUB_INVESTIGATOR) Devon Knotts (SUB_INVESTIGATOR) |
Find similar trials in Birmingham, AL
By research site
Related Studies
- Identification of Pre-Malignant Lesions In Pediatric Patients With Neurofibromatosis Type 1 Using Novel Magnetic Resonance Imaging Techniques Paired With Artificial IntelligenceRecruiting · Nicole Baca · Los Angeles, California
- Developing Biomarkers of Plexiform Tumor Burden in Patients With Neurofibromatosis-Type 1Enrolling By Invitation · Ann & Robert H Lurie Children's Hospital of Chicago · Chicago, Illinois
- A Study to Evaluate the Feasibility of a Physiologic Biomarker to Assess Pain and Other Sensory Problems Using Pupillometry in Participants With Neurofibromatosis Type 1 (NF1)Recruiting · National Cancer Institute (NCI) · Washington D.C., District of Columbia
- Development of Patient-Reported Outcome Measures Assessing Tumor Visibility and Appearance Concerns in Neurofibromatosis Type 1: A Qualitative StudyRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland